Skip to main content
Caplight Logo









Ottehr

Ottehr

Private
United StatesHealthcare & Life Scienceshttps://www.ottehr.com/

Last Round

Accelerator

Dec 15, 2023

Company Overview

Ottehr operates in Healthcare & Life Sciences and is based in the United States. Its latest recorded funding round was an Accelerator round in December 2023.

Ottehr is a health-tech company that provides an open-source, FHIR-native electronic health record (EHR) platform designed for urgent care and ambulatory workflows.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Telemedicine, Revenue Cycle, Patient Engagement, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ottehr Comparables

Compare Ottehr with similar companies based on industry and business-model similarity.

Ottehr comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medplum
89%
Healthie
76%
Oystehr
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ottehr Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 15, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ben Lundin

Chief Strategy Officer

Executive Team

For institutional investors. Book with your work email.

Ottehr Investors

Notable investors and investment history

Ottehr investors
InvestorRounds
MassLightAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Monthly visitors increased 59% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ottehr Filings

Explore SEC and related filing metadata, where available.

Ottehr filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ottehr's valuation, stock price, and market status.

Is Ottehr a public or private company?

Ottehr is a private company.

What is the current stock price of Ottehr?

Ottehr is a private company, so its shares have no public market price. Caplight tracks Ottehr's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ottehr worth (valuation)?

Valuation information for Ottehr is not publicly available.

Can I buy Ottehr stock?

Ottehr shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ottehr's last funding round?

Ottehr's most recent funding round was Accelerator on December 15, 2023.

Who are the main investors in Ottehr?

Key investors in Ottehr include MassLight.

Will Ottehr IPO soon?

No public IPO plans have been announced for Ottehr.

How can I track Ottehr secondary market activity?

Caplight tracks bids, offers, and trades in Ottehr's shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Employee Range3
Year Founded2022
Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?